How to buy AtriCure (ATRC) stock

AtriCure, Inc is a medical instruments & supplies business based in the US. AtriCure shares (ATRC) are listed on the NASDAQ and all prices are listed in US Dollars. AtriCure employs 750 staff and has a trailing 12-month revenue of around 0.00.

AtriCure stock price (NASDAQ: ATRC)

Use our graph to track the performance of ATRC stocks over time.

AtriCure shares at a glance

• Key figures

Information last updated 2021-07-22.

Latest market close	$74.73
52-week range	$34.04 - $83.85
50-day moving average	$77.97
200-day moving average	$68.55
Wall St. target price	$88.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.57

Buy AtriCure shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy AtriCure stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of AtriCure, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AtriCure price performance over time

Historical closes compared with the close of $74.73 from 2021-05-28

1 week (2021-07-13)	N/A
1 month (2021-06-24)	-4.89%
3 months (2021-04-20)	N/A
6 months (2021-01-20)	N/A

1 year (2020-07-20)	N/A
2 years (2019-07-20)	N/A
3 years (2018-07-20)	N/A
5 years (2016-07-20)	N/A

AtriCure financials

Revenue TTM	$212.6 million
Gross profit TTM	$149.3 million
Return on assets TTM	-3.96%
Return on equity TTM	-15.73%
Profit margin	-22.89%
Book value	$8.58
Market capitalisation	$3.7 billion

TTM: trailing 12 months

Shorting AtriCure shares

There are currently 1.9 million AtriCure shares held short by investors – that's known as AtriCure's "short interest". This figure is 1.5% down from 1.9 million last month.

There are a few different ways that this level of interest in shorting AtriCure shares can be evaluated.

AtriCure's "short interest ratio" (SIR)

AtriCure's "short interest ratio" (SIR) is the quantity of AtriCure shares currently shorted divided by the average quantity of AtriCure shares traded daily (recently around 304356.43879173). AtriCure's SIR currently stands at 6.29. In other words for every 100,000 AtriCure shares traded daily on the market, roughly 6290 shares are currently held short.

However AtriCure's short interest can also be evaluated against the total number of AtriCure shares, or, against the total number of tradable AtriCure shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AtriCure's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 AtriCure shares in existence, roughly 40 shares are currently held short) or 0.0431% of the tradable shares (for every 100,000 tradable AtriCure shares, roughly 43 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against AtriCure.

Find out more about how you can short AtriCure stock.

AtriCure share dividends

We're not expecting AtriCure to pay a dividend over the next 12 months.

AtriCure share price volatility

Over the last 12 months, AtriCure's shares have ranged in value from as little as $34.04 up to $83.85. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AtriCure's is 1.0724. This would suggest that AtriCure's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

AtriCure overview

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally. It offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. The company also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used to treat symptomatic persistent and long-standing persistent atrial fibrillation patients; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, it sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; COBRA Fusion Surgical Ablation System; Fusion Magnetic Retriever System; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. The company markets and sells its products through independent distributors and direct sales personnel. AtriCure, Inc.

Frequently asked questions

What percentage of AtriCure is owned by insiders or institutions?
Currently 2.997% of AtriCure shares are held by insiders and 99.901% by institutions. How many people work for AtriCure?
Latest data suggests 750 work at AtriCure. When does the fiscal year end for AtriCure?
AtriCure's fiscal year ends in December. Where is AtriCure based?
AtriCure's address is: 7555 Innovation Way, Mason, OH, United States, 45040 What is AtriCure's ISIN number?
AtriCure's international securities identification number is: US04963C2098 What is AtriCure's CUSIP number?
AtriCure's Committee on Uniform Securities Identification Procedures number is: 04963C209